NR4A1 and breast cancer: Consistent with our findings, in a previous study STC2 levels were analysed in 110 breast cancer cases and found to be associated with favourable prognosis in hormone receptor (HR)-positive breast cancer patients treated with adjuvant hormone therapy [54].